Home » CLL Programs & Support » On Demand Educational Activities
Education On-Demand
Education On-Demand
The varied educational activities offered by CLL Society are your opportunities to learn basic information, dive deep into specific topics, or stay abreast of cutting-edge news and research presented in the form of webinars, educational forums, and other learning modules.
FEATURE
Recorded Monday, September 9, 2024
Navigating Medicare is no easy task. Ahead of open enrollment, bring your questions and also learn about two new programs expected to help cancer patients significantly reduce or manage out of pocket costs.
EDUCATION ON-DEMAND
Introduction to CLL and Newly Diagnosed
- Treatment for CLL: When is the Right Time to Start?
- The Current Role of Measurable Residual Disease Testing: Featuring Dr. Tara Graff & Dr. Brian Koffman
- Beyond Your CLL Diagnosis: Comprehensive Health Management
- Beyond the Diagnosis: Surviving and Thriving with CLL / SLL
- The Importance of Front-Loading Your Knowledge During the Early Journey of CLL / SLL
- Just Diagnosed: What Do I Need to Know?
- Understanding How Biomarkers Help Guide Treatment Decisions for Those with CLL / SLL
- Immunity and CLL: It’s Complicated but Understandable
- Health and Wellness: Beyond the Medicine Cabinet
- Global Virtual Patient & Caregiver Educational Forum
- Huntsman 5th Annual Patient & Caregiver Educational Forum
- Huntsman 6th Annual Patient & Caregiver Educational Forum
- Getting Maximum Benefit from Doctor Appointments
- Learning to Decode Your Blood Test Results for CLL
- CLL Society Ed Forum On Demand: The Right Tests at the Right Time
- CLL Society Webinar: A Psychological Perspective: Dealing with the CLL Emotional Roller Coaster
- CLL Society Patient Education Forum at the City of Hope, January 11, 2020
CLL Treatments and Breaking Research
- Playing CLL / SLL Chess: Planning Your Therapy Moves
- Webcast Podcast – Deep Dive into Five: Planning Your Therapy Moves
- CAR-T and Other Cellular Therapies in CLL: The Present and Future
- The Evolving Role of BTKi’s in CLL
- Is a Clinical Trial Right for You?
- ASH 2023 Comes to You!
- ASH 2022 Comes to You!
- ASH 2021 Comes to You!
- CLL Society Ed Forum On Demand: ASH 2020 Comes to You
- CAR-T Ed Forum: The Basic Science and Latest Data
- The Future of CAR-T Therapy: Can CAR-T Cure CLL?
- Revisiting PI3K Inhibitors for the Treatment of CLL: Are They Living Up to Their Promise?
Other Topics
- Your Medicare Guide: Tackling Costs and Answering Your Questions
- Fixed Duration vs. Continuous Duration Therapies
- Time Off Treatment
- A Matching-Adjusted Indirect Comparison (MAIC) Case Study: Zanubrutinib vs. Acalabrutinib
- The Current Role of Measurable Residual Disease Testing: Featuring Dr. Tara Graff & Dr. Brian Koffman
- MRD: What Should It Mean to Me?
- Navigating Integrative Medicine Approaches in CLL
- Why Policy Matters: Understanding How Your CLL / SLL Journey is Affected
- Being Your Own Cancer Advocate
- Money Matters: Help Is There to Prevent Financial Toxicity
- Giving Care to the Caregiver
- Veterans with CLL: How to Get the Benefits and Care You Deserve
- A Brighter Future for CLL: Learn How Your Legacy Can Have a Lasting Impact
- Planning Ahead: Being Prepared for End of Life
Ask Me Anything - Facebook Live Events
- Ask Me Anything: Featuring Dr. Richard Furman and Jeff Folloder (a Facebook Live Event)
- Ask Me Anything: Featuring Dr. Deborah Stephens and Doreen Zetterlund (a Facebook Live Event)
- Ask Me Anything: Featuring Dr. Sameer Parikh and Jeff Folloder (a Facebook Live Event)
- Ask Me Anything: Featuring Dr. Matthew Davids and Doreen Zetterlund (a Facebook Live Event)
- Ask Me Anything: Featuring Dr. Brian Hill and Jeff Folloder (a Facebook Live Event)
- Ask Me Anything: Featuring Dr. Brian Koffman and Michele Nadeem-Baker (a Facebook Live Event)
- Ask Me Anything: Featuring Dr. Nicole Lamanna and Doreen Zetterlund (a Facebook Live Event)
X Spaces Events
COVID-19 Webinars
- COVID-19 in 2024: Recommendations and Strategies for Those with CLL and SLL
- Preventing COVID-19 and Other Respiratory Infections in Those with CLL / SLL During Peak Winter Months
- Performing a COVID-19 Risk Assessment: Understanding What Has Changed Now That the Government Response Has Scaled Down – June 27, 2023
- The Changing Face of COVID-19: What it Means for the Immunocompromised – January 12, 2023
- It’s Not Over Yet: The Ongoing Impact of COVID-19 for Those with CLL / SLL – August 24, 2022
- Is There Good News Ahead? Update on Omicron and Beyond Available Therapies for COVID-19 – March 19, 2022
- COVID-19: Are Monoclonal Antibodies What the CLL Community Has Been Waiting For? – December 2, 2021
- The Delta Variant and Staying Protected — September 24, 2021
- Contagion, Variants, and Vaccines — March 26, 2021
- Managing Re-Entry — June 18, 2020
- Overview of Current Information Available — April 17, 2020
- Overview of Current Information Available — April 3, 2020
- Overview of Current Information Available — March 27, 2020
Additional Education Not to Miss from Our Partners
- Forming a United Front Against CLL: The Patient-Healthcare Team Partnership on Treatment Choices & Sequential Care
- Noncovalent BTK Inhibitors New Targeted Options for Relapsed or Refractory Chronic Lymphocytic Leukemia
- Advocating for Quality CLL Care: Strategies Based on Real-World Data and Patient Experiences
- From Resistance to Resilience in R/R CLL: Sequencing Strategies for Achieving Effective Continuous Care
- Controlling and Conquering CLL: Guidance on Modern Targeted Options, Innovative Combinations, and Sequential Management
- Taking Direction From Biomarkers and Prognostic Factors in CLL: Interprofessional Strategies for Addressing Challenges With Continuous BTKi Therapy
- Defying the Odds With Innovation in CLL: Perspectives on Personalized Care, Multiagent Platforms, and Sequential Strategies
- Leading Change, Leading Advances in CLL Care: Guidance on Delivering Modern Targeted and Cellular Therapeutics
- Fine-Tuning the Wave of Innovation in CLL: Personalized Models for Upfront and Sequential Care with Groundbreaking Treatment
- Rewriting the Treatment Script in CLL: Guidance on Integrating Modern Targeted and Next-Gen Options Into Patient Care
- Hope is Here in CLL: Oncology Nurse Strategies for Delivering Effective, Compassionate, and Modern Care to Patients
- Immunocompromised: Navigating the COVID-19 Pandemic While Living with CLL
- Optimal CLL Care Through Healthcare Professional and Patient Education
- Toward a Brighter Future for Preventing COVID-19 in Patients with Hematologic Malignancies: Leveraging the Power of Current Strategies and Next-Generation Agents
BROWSE ALL EDUCATION
Forming a healthcare team devoted to engaging in informed, shared decision making is important to getting the best possible outcomes with your care.
Dr. Chadi Nabhan, Dr. Brian Koffman, Dr. Adam Kittai, and Dr. Alan Skarbnik joined us for an X Spaces event to discuss the exciting data on chronic lymphocytic leukemia (CLL) that was presented at the American Society of Clinical Oncology (ASCO) Annual Meeting held May 31- June 4, in
Dr. Chadi Nabhan, Dr. Brian Koffman, and Dr. Adam Kittai join us for an X (Twitter) Space event to discuss the exciting data on chronic lymphocytic leukemia (CLL) that was presented at the American Society of Hematology (ASH) Annual Meeting held December 9-12, 2023, in San Diego, CA.
Join Dr. Koffman as he and Dr. Adrian Wiestner discuss A New Oral BTK Protein Degrader: A novel drug designed to overcome resistance to BTK Inhibitors.
Dr. Matthew Davids joins us for CLL Society’s Facebook Live Event “Ask Me Anything”. With no prepared presentation, this event is truly dedicated to answering your questions.
Recorded June 27, 2023 https://youtu.be/x19FUHb4KvQ While the Public Health Emergency for COVID-19 has ended, the pandemic itself has not yet been declared over. Although thankfully hospitalizations and death rates have been declining, the virus continues to mutate and spread. Join Dr. Ghady Haidar, Dr. Brian Koffman, and Robyn Brumble,
Dr. Chadi Nabhan, Dr. Brian Koffman, and Dr. Nitin Jain join us for a Twitter Space event to discuss the exciting data on CLL at ASCO 2023.
We will discuss the most common biomarkers found in CLL / SLL, when and how to test for them using CLL Society’s Test Before Treat™.
Please join CLL Specialist, Dr. Joanna Rhodes as she explains diagnostic and prognostic testing, and other tips for maintaining your overall health.
Dr. Brian Hill joins us for CLL Society’s Facebook Live Event “Ask Me Anything”. With no prepared presentation, this event is truly dedicated to answering your questions.